Detalhe da pesquisa
1.
Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia.
Haematologica
; 107(7): 1599-1607, 2022 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34551507
2.
Erratum to: Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia.
Haematologica
; 109(4): 3010, 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38562076
3.
Quality of life from the perspective of the patient with acute myeloid leukemia.
Cancer
; 124(1): 145-152, 2018 Jan 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28881384
4.
Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis.
Haematologica
; 102(5): 865-873, 2017 05.
Artigo
Inglês
| MEDLINE | ID: mdl-28126965
5.
Number of courses of induction therapy independently predicts outcome after allogeneic transplantation for acute myeloid leukemia in first morphological remission.
Biol Blood Marrow Transplant
; 21(2): 373-8, 2015 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-25278455
6.
A phase I/II study of oral clofarabine plus low-dose cytarabine in previously treated acute myeloid leukaemia and high-risk myelodysplastic syndrome patients at least 60 years of age.
Br J Haematol
; 170(3): 349-55, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25854284
7.
Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.
Blood
; 122(10): 1813-21, 2013 Sep 05.
Artigo
Inglês
| MEDLINE | ID: mdl-23847197
8.
Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms.
Haematologica
; 104(4): e143-e146, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30409798
9.
Prediction of adverse events during intensive induction chemotherapy for acute myeloid leukemia or high-grade myelodysplastic syndromes.
Am J Hematol
; 89(4): 423-8, 2014 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-24382796
10.
Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis.
Blood Adv
; 7(19): 5835-5842, 2023 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37552106
11.
Development and validation of the AML-QOL: a quality of life instrument for patients with acute myeloid leukemia.
Leuk Lymphoma
; 61(5): 1158-1167, 2020 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31909637
12.
Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis.
Blood Adv
; 4(22): 5825-5835, 2020 11 24.
Artigo
Inglês
| MEDLINE | ID: mdl-33232476
13.
A comparison of patients with acute myeloid leukemia and high-risk myelodysplastic syndrome treated on versus off study.
Leuk Lymphoma
; 60(4): 1023-1029, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30277112
14.
Successful Treatment of Cannabinoid Hyperemesis Syndrome with Topical Capsaicin.
ACG Case Rep J
; 5: e3, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-29379817
15.
Patient-reported outcomes in acute myeloid leukemia: Where are we now?
Blood Rev
; 32(1): 81-87, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28888621
16.
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.
Leukemia
; 32(11): 2352-2362, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-29720734
17.
Outpatient care of patients with acute myeloid leukemia: Benefits, barriers, and future considerations.
Leuk Res
; 45: 53-8, 2016 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27101148
18.
Lymphomatoid granulomatosis associated with azathioprine use for immune-mediated neuropathy.
BMJ Case Rep
; 20162016 Sep 26.
Artigo
Inglês
| MEDLINE | ID: mdl-27671987
19.
Comparison of outpatient care following intensive induction versus post-remission chemotherapy for adults with acute myeloid leukemia and other high-grade myeloid neoplasms.
Leuk Lymphoma
; 62(1): 234-238, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32921204
20.
Antigen-specific immunotherapies for acute myeloid leukemia.
Hematology Am Soc Hematol Educ Program
; 2015: 584-95, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26637776